![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
Tagged: business, india, launch, bse, nod, lungs, generic drugs, bombay stock exchange, cystic fibrosis, global market, strategic marketing, patent applications, digestive system
Mumbai, March 3 (IANS) The Drug Controller General of India (DCGI) has given a green signal to Punjab-based Venus Remedies Ltd for the launch of its latest antibiotic drug, which it says has a $2.5-billion global market. Announcing this here, the company in its statement said that this drug is used in the life threatening [...] … Continue Reading »